Search ARM

Mnemo Therapeutics is driven to create cures using a unique and fully integrated T cell therapy platform (EnfiniT). Mnemo is developing powerful T cell technologies by using a combination of epigenetic tools and advanced T cell engineering to enhance cell therapy persistence and with the ability to detect extremely low levels of antigen. We have a revolutionary target ID platform that we will deploy, based on newly identified junctions between exons and transposable elements (JETs). Our experienced leadership includes seminal partnerships with Institut Curie and MSKCC, as well as a strong syndicate of investors and a visionary and talented management team.

Contact Mnemo Therapeutics
Visit Website